December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

4.900 +0.870 (+21.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
30 31 Next >
News headline image
Allied, Cybin Among Top Psychedelic Movers Of Today ↗
  
Via Benzinga
News headline image
Recap: ATAI Life Sciences Q2 Earnings ↗
  ATAI Life Sciences (NASDAQ:ATAI) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Major Psychedelic Stocks Down This Week; Still Up Since End Of June ↗
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then. 
Via Talk Markets
News headline image
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today ↗
  
Via Benzinga
News headline image
ATAI Life Sciences Earnings: A Preview ↗
  ATAI Life Sciences (NASDAQ:ATAI) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For August 15, 2022 ↗
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
  
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From August 10, 2022 ↗
  
Via Benzinga
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... 
Via FinancialNewsMedia
Topics Supply Chain
News headline image
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today ↗
  
Via Benzinga
News headline image
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From August 4, 2022 ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17 
Via Benzinga
News headline image
Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone ↗
Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player 
Via Benzinga
News headline image
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
News headline image
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD ↗
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From July 29, 2022 ↗
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22 
Via Benzinga
InvestorNewsBreaks – Atai Life Sciences (NASDAQ: ATAI) Featured in Analysis Report
Via Investor Brand Network
Topics Derivatives
News headline image
Allied, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55 
Via Benzinga
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06 
Via Benzinga
News headline image
Allied, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55 
Via Benzinga
News headline image
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam... 
Via FinancialNewsMedia
Topics Law Enforcement
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From July 22, 2022 ↗
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50 
Via Benzinga
News headline image
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45 
Via Benzinga
News headline image
Dear Psychedelic Stocks Fans, Watch This Key Catalyst ↗
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support. 
Via InvestorPlace
News headline image
Psychedelic Stock Gainers And Losers From July 20, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11 
Via Benzinga
News headline image
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93 
Via Benzinga
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02 
Via Benzinga
News headline image
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment ↗
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs. 
Via Talk Markets
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.